摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.75
  • 重原子数:
    19
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.53
  • 拓扑面积:
    21.5
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

点击查看最新优质反应信息

文献信息

  • Synthesis of new mono-N-tosylated diamine ligands based on (R)-(+)-limonene and their application in asymmetric transfer hydrogenation of ketones and imines
    作者:Piotr Roszkowski、Jan K. Maurin、Zbigniew Czarnocki
    DOI:10.1016/j.tetasy.2013.04.010
    日期:2013.6
    preparation of a new family of enantiopure mono-N-tosylated-1,2-diamines derived from (R)-(+)-limonene is described. (+)-Limonene was transformed into the appropriate N-tosyl derivative using N-tosylaziridination based on chloramine-T trihydrate. Subsequent ring opening by sodium azide afforded the corresponding isomeric azides. Finally, reduction of the azide function gave enantiomerically pure mono-N-tosylated-1
    描述了一种合成方法,该方法可制备新的对映体纯的,衍生自(R)-(+)-柠檬烯的单-N-甲苯磺酰基-1,2-二胺。使用基于氯胺-T三合物的N-甲苯磺酰基叠氮化将(+)-柠檬烯转化为合适的N-甲苯磺酰基衍生物。随后通过叠氮开环得到相应的异构叠氮化物。最后,叠氮化物功能的降低得到对映体纯的单-N-甲苯磺酸化的1,2-二胺。事实证明,所获得的配体在芳族酮和亚胺的不对称转移氢化方案中是有效的。
  • A Highly Enantioselective Access to Tetrahydroisoquinoline and β-Carboline Alkaloids with Simple Noyori-Type Catalysts in Aqueous Media
    作者:Laurent Evanno、Joel Ormala、Petri M. Pihko
    DOI:10.1002/chem.200902289
    日期:2009.12.7
    enhancement: A very convenient modified protocol for the enantioselective transfer hydrogenation of dihydroisoquinoline skeletons under aqueous conditions is reported. Unmodified Noyori ligands can be used and the activity of the catalyst is greatly enhanced with silver additives (see scheme). The protocol was used in a very short synthesis of the alkaloids (S)‐harmicine and (S)‐crispine.
    增强:报道了在性条件下用于二氢异喹啉骨架的对映选择性转移氢化的非常方便的改进方案。可以使用未改性的Noyori配体,并且使用添加剂可以大大提高催化剂的活性(参见方案)。该协议被用于非常短的生物碱(S)-甜菜碱和(S)-crispine的合成。
  • Asymmetric Synthesis of Fused-Ring Tetrahydroisoquinolines and Tetrahydro-β-carbolines from 2-Arylethylamines via a Chemoenzymatic Approach
    作者:Linsong Yang、Jianjiong Li、Zefei Xu、Peiyuan Yao、Qiaqing Wu、Dunming Zhu、Yanhe Ma
    DOI:10.1021/acs.orglett.2c02466
    日期:2022.9.16
    While chiral fused-ring tetrahydroisoquinoline (THIQ) and tetrahydro-β-carboline (THβC) scaffolds have attracted considerable interest due to their wide spectrum of biological activities, the synthesis of optically pure chiral fused-ring THIQs and THβCs remains a challenging task. Herein, a group of active imine reductases were identified to convert the imine precursors into the corresponding enantiocomplementary
    虽然手性稠环四氢异喹啉 (THIQ) 和四氢-β-咔啉 (THβC) 支架因其广泛的生物活性而引起了相当大的兴趣,但合成光学纯的手性稠环 THIQs 和 THβCs 仍然是一项具有挑战性的任务。本文鉴定了一组活性亚胺还原酶,将亚胺前体转化为具有高对映选择性和转化率的相应的对映互补稠环 THIQ 和 THβC,建立了一种从 2-芳基乙胺制备稠环生物碱的高效绿色化学酶法。
  • V.—1-ω-Halogenoalkylisoquinolines and their derivatives
    作者:Reginald Child、Frank Lee Pyman
    DOI:10.1039/jr9310000036
    日期:——
  • Synthesis of aza-macrocycles from polycyclic 5-aminoisoxazoline precursors
    作者:Mark P. Wentland、Rudolph K. Kullnig、Fook S. Tham
    DOI:10.1021/jo00015a025
    日期:1991.7
    A series of novel isoxazolo analogues 11 of the dibenzazonine alkaloid protostephanine (1) has been prepared. A new regiospecific and potentially general aza macrocyclic ring forming process was developed where the first step was the 1,3-dipolar cycloaddition of benzonitrile oxide to the readily available enamine 6. The product, isoxazoline 9a, under solvolytic conditions that normally convert monocyclic 5-aminoisoxazolines to isoxazoles failed to give the desired aza macrocycle 14. Alternate sequences involving quaternization of 9a with methyl iodide followed by either solvolysis in polar solvents or base-induced elimination were successful and gave the target structure 11a in excellent overall yield. X-ray crystallographic analysis of the quaternized intermediate 10a corroborated the assignment of structure and defined the crystal-state conformation.
查看更多

同类化合物

法莫汀 诺斯卡品杂质2 美莫汀盐酸盐 美莫汀 法莫汀盐酸盐 氯化可替宁 异喹啉,3,4-二氢-6,7-二甲氧基-3,3-二甲基- 异喹啉,3,4-二氢-6,7-二甲氧基-1-苯基-,盐酸 异喹啉,3,4-二氢-5,6,7-三甲氧基-1-甲基- 丁-2-烯二酸;7-甲基-3-[(4-甲基哌嗪-1-基)甲基]-1-苯基-3,4-二氢异喹啉 7-苄氧基-6-甲氧基-3,4-二氢异吲哚 7-羟基-6-甲氧基-3,4-二氢异喹啉 7-硝基-3,4-二氢异喹啉 7-甲基-3,4-二氢异喹啉 7-溴二氢异喹啉 7-溴-3,4-二氢异喹啉盐酸盐 7-溴-1-异丙基-3,4-二氢异喹啉 7-氯-1-苯基-3,4-二氢异喹啉 7-氟-3,4-二氢异喹啉 7-氟-1-甲基-3,4-二氢异喹啉 7,8-二甲氧基-3,4-二氢异喹啉 7,8-二氢-[1,3]二氧代[4,5-g]异喹啉 7,8-二氢-5-[4-(异丙基磺酰基)苯基]-1,3-二氧杂环戊并[4,5-g]异喹啉 6-苄氧基-7-甲氧基-3,4-二氢-异喹啉 6-羟基-7-甲氧基-2-甲基-3,4-二氢异喹啉正离子 6-甲氧基-3,4-二氢-异喹啉 6-甲氧基-2-苯基-1-(3-(三氟甲基)苯基)-3,4-二氢异喹啉-2-碘化物 6-甲氧基-1-甲基-3,4-二氢异喹啉 6-氯-1-(2-氯-苯基)-7-甲氧基-3,4-二氢-异喹啉 6-氯-1-(2-异丙基-苯基)-7-甲氧基-3,4-二氢-异喹啉 6-氯-1-(2,6-二甲基-苯基)-7-甲氧基-3,4-二氢-异喹啉 6-氟-3,4-二氢异喹啉 6,7-二甲氧基-3-甲基-3,4-二氢异喹啉盐酸盐 6,7-二甲氧基-3,4-二氢异喹啉盐酸盐 6,7-二甲氧基-3,4-二氢异喹啉 6,7-二甲氧基-1-(4-甲氧基苯基)-3,4-二氢异喹啉 6,7-二甲氧基-1-(3,4-二甲氧基苯基)-3-羟基甲基-3,4-二氢异喹啉 6,7-二甲氧基-1,3,3-三甲基-3,4-二氢异喹啉氢碘化 6,7-二甲-1,3-二甲基-3,4-二氢异喹啉盐酸盐 6,7-二乙氧基-3,4-二氢异喹啉盐酸盐 5-甲氧基-1-甲基-3,4-二氢异喹啉 5-甲基吡咯-3-腈 5-甲基-7,8-二氢-[1,3]二氧戊环并[4,5-G]异喹啉 5-甲基-3,4-二氢-异喹啉 5-氯-2-(6,7-二甲氧基-3,4-二氢异喹啉-1-基)苯胺 5,8-二甲氧基-3-甲基-3,4-二氢-异喹啉 4-甲氧基-7,8-二氢[1,3]二氧杂环戊并[4,5-g]异喹啉 4-甲氧基-6-甲基-7,8-二氢[1,3]二氧杂环戊并[4,5-g]异喹啉-6-鎓碘化物 4-氯-2-(6,7-二甲氧基-3,4-二氢异喹啉-1-基)苯胺 4-(6,7-二甲氧基-3,4-二氢异喹啉-1-基)庚二腈